Abstract: A compound of the formula (I): as defined herein, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing a compound of the formula (I) for use in inhibiting hepatitis C virus polymerase and/or of treating or preventing an illness due to hepatitis C virus,
Type:
Application
Filed:
March 25, 2008
Publication date:
May 13, 2010
Applicant:
ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANG
Inventors:
Uwe Koch, Angela Claire Mackay, Frank Narjes, Ian Stansfield
Abstract: The present invention relates to the use of trifluoroacetylated lysine (Boc-L-Lys(?- trifluoroacetyl)-MCA) as a substrate for histone deacetylases, specific for the class Ha subtype.
Type:
Application
Filed:
September 5, 2006
Publication date:
May 28, 2009
Applicant:
ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANG